Olanzapine for Chemotherapy-induced Nausea and Vomiting Prophylaxis
To investigate that olanzapine can reduced side effect about nausea and vomiting in women with gynecologic cancers receiving carboplatin-based regimen by using olanzapine and placebo
Complete Response Rate to Chemotherapy-induced Nausea and Vomiting Prophylaxis
DRUG: Olanzapine 10 Mg ORAL TABLET|DRUG: Olanzapine 5 Mg ORAL TABLET|DRUG: Placebo ORAL TABLET
Complete response rate of chemotherapy-induced nausea and vomiting prophylaxis, No breakthrough vomiting and no using rescue therapy, 5 days after chemotherapeutic administration
Episodes of vomiting, 5 days after chemotherapeutic administration|Severity of nausea, 5 days after chemotherapeutic administration|Use of rescue drug, using of rescue anti-emetic medication, 5 days after chemotherapeutic administration|Quality of life associated with nausea and vomiting measured using Functional Living Index-Emesis (FILE), 5 days after chemotherapeutic administration
A double-blind, placebo-controlled, randomized crossover trial